Stay updated on Nivolumab Ramucirumab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the previous funding-status notice (Revision: v3.4.1). No changes to the study data or substantive content are observed.
    Difference
    0.5%
    Check dated 2026-02-11T02:13:43.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    General site updates include a government funding notice banner at the top of the page and a revision tag showing v3.4.1; these changes do not affect the study content such as eligibility criteria or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T00:36:52.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle in the header/footer and updates the study metadata to include Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0, while removing the older labels Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. These are minor UI/metadata updates that do not affect core content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-27T23:18:22.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The study status changed from Recruiting to Active, not recruiting, and enrollment was updated to 36. Study contact and investigator information was removed.
    Difference
    2%
    Check dated 2026-01-20T22:52:56.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision update from v3.3.3 to v3.3.4 with no changes to the study content, endpoints, eligibility criteria, or contact details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:24:38.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Locations section updated to list study sites in New York and Pennsylvania under a single Locations section, consolidating the prior 'New York Locations' and 'Pennsylvania Locations' entries.
    Difference
    0.3%
    Check dated 2025-12-23T09:46:23.000Z thumbnail image

Stay in the know with updates to Nivolumab Ramucirumab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page.